?> Contact us Follow Us
Biosimilars Forum
  • About Us
    • Members
    • Executive Director
  • Why Biosimilars
    • The Issue
    • Our Solutions
  • Biosimilars 101
    • Foundations
    • Core Principles
    • FDA Regulatory Tenets
    • Biosimilars FAQs
    • Future Evolution of Biosimilar Development
    • Approved Biosimilars
  • Advocacy
    • Our Action
    • Tools
  • News
  • Resources
  • Get Involved
    • Partners

signalgroup

Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
November 10, 2022 signalgroup
Dorothy McCabe Member Spotlight
News
November 3, 2022 signalgroup
Biosimilars Forum Wins Global Biosimilars Industry Partner of the Year at Global Generics & Biosimilars Awards
News
October 4, 2022 signalgroup
Biosimilars Forum Applauds CMS Biosimilars Measure
News
October 4, 2022 signalgroup
Inflation Reduction Act – ASP+8 Biosimilars Payment Increase
News
September 20, 2022 signalgroup
ASP +8: CMS Releases Biosimilars Information
News
August 6, 2022 signalgroup
Biosimilars Forum Warns Limited Negotiation Policies Will Stymie Innovation
News
July 28, 2022 signalgroup
Hillel Cohen Member Spotlight
News
July 21, 2022 signalgroup
The Biosimilars Forum Launches Updated Website Content
News
July 14, 2022 signalgroup
Rebecca Mandell Member Spotlight
News
June 22, 2022 signalgroup
The Biosimilars Forum Welcomes Legislation to Hold PBMs Accountable for Unfair Practices
  • Prev page
  • 02
  • 03
  • 04
  • 05
  • 06
  • Next page

  • Biosimilars 101
  • Biosimilars FAQs
  • Advocacy
  • Stay Connected
Biosimilars Forum
© 2025 Biosimilars Forum. All rights reserved.
  • Terms of Use
  • |
  • Privacy Policy
  • |
  • Contact Us